Subclinical organ damage in perimenopausal women with essential hypertension

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 10, 2010, Pages 390-398

  Olszanecka, Agnieszka ^a   Pośnik Urbańska, Aneta ^a   Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Hypertension; Menopause; Subclinical organ damage

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CAROTID ARTERY PULSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MENOPAUSE; ORGAN INJURY; POSTMENOPAUSE; PREMENOPAUSE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

EID: 78650551455     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.977     Document Type: Article

References (36)

1. Peterson S, Peto V, Rayner M, Luengo-Femandez R, et al. European Cardiovascular Disease Statistics. 2nd ed. London, UK: British Heart Foundation; 2005.
2. Edmunds E, Lip GY. Cardiovascular risk in women: the cardiologist's perspective. QJM. 2000;93:135-145.
3. Pośnik-Urbańska A, Kawecka-Jaszcz K. [Hypertension in postmenopausal women - selected pathomechanisms]. Przegl Lek. 2006;63:1313-1317. Polish.
4. Staessen JA, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens. 1997;11:507-514.
5. Zanchetti A, Facchetti R, Cesana GC, et al.; SIMONA participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study J Hypertens. 2005;23:2269-2276.
6. Cifkova R, Pitha J, Lejskova M, et al. Blood pressure around the menopause: a population study. J Hypertens. 2008;26:1976-1982.
7. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reapprisal of European guidelines on hypertension management: a European Society of Hypertension Task Force Document. Blood Press. 2009;18:308-347.
8. Mancia G, De Backer G, Dominiczak A, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
9. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol. 1997;29:862-879.
10. Cuspidi C, Giudici V, Negri F, et al. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height (2.7). J Hypertens. 2009;27:2465-2471.
11. Quiñones MA, Otto CM, Stoddard M, et al.; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167-184.
12. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J. 2007;28:2539-2550.
13. Freire CM, Ribeiro AL, Barbosa FB, et al. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice. Vasc Health Risk Manag 2009;5:811-817.
14. Rajzer MW, Wojciechowska W, Klocek M, et al. Comparison of aortic pulse wave velocity measured by three techniques' Complior, SphygmoCor and Arteriograph. J Hypertens. 2008;26:2001-2007.
15. Collins A, Sethi M, MacDonald FA, et al. Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia. 1993;36:993-997.
16. Casiglia E, Tikhonoff V, Caffi S, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens. 2008;26:1983-1992.
17. Kuh D, Langenberg C, Hardy R, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study. BJOG. 2005;112:476-485.
18. van Beresteyn ECH, van t Hof MA, de Waard H. Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study Am J Epidemiol. 1989;129:947-955.
19. Kawecka-Jaszcz K, Czarnecka D, Dembinska-Kieć A, et al. Insulin resistance and lipids in hypertensive women on hormone replacement therapy. Blood Press. 2002;11:28-34.
20. Taylor HA, Penman AD, Han H, et al. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities. [ARIC] study). Am J Cardiol. 2007;99:1413-1420.
21. Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women. J Hypertens Suppl. 2002;20: S34-S38.
22. Hinderliter AL, Sherwood A, Blumenthal JA, et al. Changes in hemodynamics and left ventricular structure after menopause. Am J Cardiol. 2002;89:830-833.
23. Pines A, Fisman EZ, Levo Y, et al. Menopause-induced changes in left ventricular wall thickness. Am J Cardiol. 1993;72:240-241.
24. Schillaci G, Verdecchia P, Borgioni C, et al. Early cardiac changes after menopause. hypertension. 1998;32:764-769.
25. Kangro T, Henriksen E, Jonason T, et al. Effect of menopause on left ventricular filling in 50-year-old women. Am J Cardiol. 1995;76:1093-1096.
26. Düzenli MA, Ozdemir K, Sokmen A, et al. Effects of menopause on the myocardial velocities and myocardial performance index. Circ J. 2007;71:1728-1733.
27. Groban L, Yamaleyeva LM, Westwood BM, et al. Progressive diastolic dysfunction in the female mRen (2). Lewis rat: influence of salt and ovarian hormones. J Gerontol A Bio Sci Med Sci. 2008;63:3-11.
28. Mercier I, Colombo F, Mader S, Calderone A. Ovarian hormones induce TGF-beta (3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res. 2002;53:728-739.
29. Staessen JA, van der Heijden-Spek JJ, Safar ME, et al. Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens. 2001;15:511-518.
30. Zaydun G, Tomiyama H, Hashimoto H, et al. Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. Atherosclerosis. 2006;184:137-142.
31. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens. 2002;16:509-516.
32. Muscelli E, Kozàkovà M, Flyvbjerg A, et al.; RISC investigators. The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women. Am J Hypertens. 2009;22:364-370.
33. Baylis C, Corman B. The aging kidney: insights from experimental studies. J Am Soc Nephrol. 1998;9:699-709.
34. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319-329.
35. Andreoli SP. Hormone replacement therapy in postmenopausal women with end-stage renal disease. Kidney Int. 2000;57:341-342.
36. Kwan G, Neugarten J, Sherman M, et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int. 1996;50:1173-1179.